Explore FHI 360

Practice Area

Research

There is an art to improving lives. And it’s in our science.

Expertise

FHI 360's clinical trials have evaluated the safety, effectiveness and acceptability of virtually every contraceptive method. For example, we are currently supporting the identification and early testing of innovative approaches to a longer-acting...

Published research

Tenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed pre-exposure prophylaxis in Sub-Saharan Africa

Published research

Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial

Published research

Seeking synergies: Understanding the evidence that links menstrual health and sexual and reproductive health and rights

Published research

Risk-based screening to identify reproductive tract infection among HIV-infected women desiring use of intrauterine contraceptives

Published research

Debunking myths about contraceptive safety among women in Kingston, Jamaica: Pilot randomized controlled trial

Published research

Optimizing the design of a contraceptive microarray patch: a discrete choice experiment on women’s preferences in India and Nigeria

Published research

Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant

Published research

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Research

Reproductive health research

Tenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed pre-exposure prophylaxis in Sub-Saharan Africa

Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial

Seeking synergies: Understanding the evidence that links menstrual health and sexual and reproductive health and rights

Risk-based screening to identify reproductive tract infection among HIV-infected women desiring use of intrauterine contraceptives

Debunking myths about contraceptive safety among women in Kingston, Jamaica: Pilot randomized controlled trial

Optimizing the design of a contraceptive microarray patch: a discrete choice experiment on women’s preferences in India and Nigeria

Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant

Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Search within these results

88 Results Found